These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31345375)

  • 21. Malignant smooth muscle tumours of soft tissue--a demographic and clinicopathological study at a tertiary care hospital.
    Shah H; Bhurgri Y; Pervez S
    J Pak Med Assoc; 2005 Apr; 55(4):138-43. PubMed ID: 15918623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
    Akin S; Dizdar O; Karakas Y; Turker A; Kars A
    Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
    Thomas WW; Fritsch VA; Lentsch EJ
    Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy.
    Prabhu RS; Hanasoge S; Magliocca KR; Hall WA; Chen SA; Higgins KA; Saba NF; El-Deiry M; Grist W; Wadsworth JT; Chen AY; Beitler JJ
    Head Neck; 2015 Jun; 37(6):777-82. PubMed ID: 24596123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
    Sun M; Liu JG; Weng QY; Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
    [No Abstract]   [Full Text] [Related]  

  • 28. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
    Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
    J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
    Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
    Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas.
    Kraus DH; Dubner S; Harrison LB; Strong EW; Hajdu SI; Kher U; Begg C; Brennan MF
    Cancer; 1994 Jul; 74(2):697-702. PubMed ID: 8033050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava.
    Cananzi FC; Mussi C; Bordoni MG; Marrari A; De Sanctis R; Colombo P; Quagliuolo V
    J Surg Oncol; 2016 Jul; 114(1):44-9. PubMed ID: 27062161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management.
    Kazlouskaya V; Lai YC; Khachemoune A
    Int J Dermatol; 2020 Feb; 59(2):165-172. PubMed ID: 31729020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization.
    Kainsbak J; Hansen ES; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():130-7. PubMed ID: 26117442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution.
    Mattavelli D; Miceli R; Radaelli S; Mattavelli F; Cantù G; Barisella M; Quattrone P; Stacchiotti S; Sangalli C; Casali PG; Gronchi A; Fiore M
    Ann Oncol; 2013 Aug; 24(8):2181-9. PubMed ID: 23562930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
    Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
    J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcome of superficial leiomyosarcoma.
    Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
    J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in head and neck soft tissue sarcomas.
    Dudhat SB; Mistry RC; Varughese T; Fakih AR; Chinoy RF
    Cancer; 2000 Aug; 89(4):868-72. PubMed ID: 10951351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
    Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
    BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.